EDGAR Filing Documents for 0001701259-17-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001701259-17-000001

Filing Date

2017-04-14

Accepted

2017-04-13 17:42:13

Documents

Effectiveness Date

2017-04-14

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	4720
	Complete submission text file	0001701259-17-000001.txt		5736

Mailing Address 7211 EXFAIR ROAD BETHESDA MD 20814

Business Address 7211 EXFAIR ROAD BETHESDA MD 20814 2408992532

Adaptive Phage Therapeutics, Inc. (Filer) CIK: 0001701259 (see all company filings)